Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00780559 · ClinicalTrials.gov registry record · NA

Improving Neuropathy and Mobility in People With Early Diabetes

A NA study of Diabetes and Physical Activity, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
72
Enrollment target
3
Study locations

NCT00780559 is a NA study of Diabetes and Physical Activity that has completed, run by VA Office of Research and Development. The registered enrollment target is 72 participants, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00780559, a NA study of Diabetes and Physical Activity, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
72 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to determine if an individually tailored diet and physical enhancement program can improve mobility, physical activity, and neuropathy in people with early diabetes.

Interventions

  • BEHAVIORAL Standard of Care
  • BEHAVIORAL Tailored Diet and Physical Activity

Study Locations (3)

Maryland

  • University of Maryland - Baltimore
  • Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD - Baltimore

Michigan

  • VA Ann Arbor Healthcare System, Ann Arbor, MI - Ann Arbor

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2009-11-01
Est. Completion 2018-02-08
Phase NA

Sponsor

VA Office of Research and Development

1,668 total trials

What the Registry Record Tells You About NCT00780559

The ClinicalTrials.gov registry entry for NCT00780559 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,028-participant average among 338 other Diabetes trials with a reported enrollment target (98% lower). The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT00780559 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Michigan.

Frequently Asked Questions

What is clinical trial NCT00780559 about?

NCT00780559 is a clinical study titled "Improving Neuropathy and Mobility in People With Early Diabetes". The purpose of this study is to determine if an individually tailored diet and physical enhancement program can improve mobility, physical activity, and neuropathy in people with early diabetes.

What is the current status of trial NCT00780559?

This trial is currently completed. It is a NA study. The enrollment target is 72 participants. The study started on 2009-11-01. Estimated completion is 2018-02-08.

What conditions does trial NCT00780559 study?

This clinical trial studies the following conditions: Diabetes, Physical Activity.

What interventions are being tested in trial NCT00780559?

The interventions under investigation include: Standard of Care (BEHAVIORAL), Tailored Diet and Physical Activity (BEHAVIORAL).

Who is sponsoring clinical trial NCT00780559?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00780559 being conducted?

This trial has 3 study locations across Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.